Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. European Institute of Oncology

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

European Institute of Oncology is an internationally renowned, non-profit comprehensive cancer center. Founded in 1994 by the prominent breast cancer surgeon and scientist Professor Umberto Veronesi, the institute operates as a recognized research hospital and treatment center (IRCCS). It seamlessly integrates cutting-edge basic and translational research with clinical prevention, diagnosis, patient care, and professional training. Hosting over 1,500 specialists, the campus features state-of-the-art infrastructure, including the highly advanced IEO Proton Center opened in 2023. Recognized globally for pioneering multidisciplinary oncological protocols and specialized surgical techniques, it stands as one of Europe’s leading anti-cancer institutions.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Cancer treatment center

Business Subcategory

Source: Human-provided. Cancer treatment center
Source: Trial-derived.
292Total Trials
Source: Trial-derived.
73Recruiting Trials
Source: Trial-derived.
156Active Trials
Source: Trial-derived.
99Completed Trials
Source: Trial-derived.
366Unique Conditions
Source: Trial-derived.
199Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (21)Source: Trial-derived. Melanoma (15)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (14)Source: Trial-derived. Ovarian Cancer (10)Source: Trial-derived. Endometrial Cancer (7)Source: Trial-derived. Head and Neck Cancer (6)Source: Trial-derived. Metastatic Breast Cancer (6)Source: Trial-derived. Advanced Solid Tumor (5)

Sponsors

Source: Trial-derived. European Institute of Oncology (28)Source: Trial-derived. Merck Sharp & Dohme LLC (28)Source: Trial-derived. Hoffmann-La Roche (26)Source: Trial-derived. Pfizer (12)Source: Trial-derived. AbbVie (11)Source: Trial-derived. Regeneron Pharmaceuticals (11)Source: Trial-derived. Janssen Research & Development, LLC (9)Source: Trial-derived. Italian Sarcoma Group (8)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. PET-CT
Source: AI-inferred. MRI
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Echocardiography
Source: AI-inferred. X-Ray

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Sequencing / genomics

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Lumbar puncture

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Cystoscopy
Source: AI-inferred. Intratumoral injection
Source: AI-inferred. Minimal residual disease (MRD) testing
Source: AI-inferred. Ophthalmologic examination
Source: AI-inferred. Tumour EGFR mutation testing
Source: AI-inferred. BRAF V600 mutation testing
Source: AI-inferred. BRAF mutation testing